Experiment Eleven

Regular price €16.99
A01=Peter Pringle
Age Group_Uncategorized
Age Group_Uncategorized
Author_Peter Pringle
automatic-update
biography doctor
biology
Category1=Non-Fiction
Category=HBT
Category=NHT
consumption tb
COP=United Kingdom
courtroom drama
cure disease
Delivery_Pre-order
eq_bestseller
eq_history
eq_isMigrated=0
eq_isMigrated=2
eq_nobargain
eq_non-fiction
historical
Language_English
medical
medical history
modern
nobel prize
PA=Temporarily unavailable
patent
Price_€10 to €20
PS=Active
rivalry
rutgers
science hospital
scientific dispute
softlaunch
vaccine

Product details

  • ISBN 9781408831069
  • Weight: 205g
  • Dimensions: 129 x 198mm
  • Publication Date: 25 Apr 2013
  • Publisher: Bloomsbury Publishing PLC
  • Publication City/Country: GB
  • Product Form: Paperback
  • Language: English
Delivery/Collection within 10-20 working days

Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock

10-20 Working Days: On Backorder

Will Deliver When Available: On Pre-Order or Reprinting

We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!

The remarkable story of a wonder drug, a disputed Nobel Prize, and a patent that shaped modern medicine

'The story of Experiment Eleven is amazing, as is its brilliant reporting, narrative verve and cool command of scientific ideas' Sylvia Nasar, author of A Beautiful Mind

'A riveting and heartbreaking book' New Scientist

In 1943, Albert Schatz, a young American Ph.D. student working in professor Selman Waksman's lab, was searching for an antibiotic to fight infections on the front lines and at home. On his eleventh experiment on a common bacterium found in farmyard soil, Schatz discovered streptomycin, the first effective cure for tuberculosis, at that time the leading killer among the world's infectious diseases.

As director of Schatz's research, Waksman took credit for the discovery, belittled Schatz's work, and secretly enriched himself with royalties from the streptomycin patent filed by Merck, the pharmaceutical company. Acclaimed author and journalist Peter Pringle unravels the intrigue behind one of the most important discoveries in the history of medicine.

Peter Pringle is a veteran British foreign correspondent and the author of several nonfiction books, including New York Times Notable, Food, Inc., and the best-selling Those Are Real Bullets, Aren't They? He has written for the New York Times and the Washington Post. He lives in New York City.